Dr Osarogiagbon speaks with ecancer at the Best of ASCO meeting in Miami to discuss rare mutations in lung cancer. He highlights the clinical significance of rare genotypes for treatment selection and prognosis, encouraging the routine testing of patient...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2uhmkda
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου